Montage Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 33.60 Cr
- Revenue Growth -38.66%
- Profit Growth -18.82%
- Ebitda -179.96%
- Net Worth -148.75%
- Total Assets -10.39%
About Montage Pharmaceuticals
Company Details
-
Location
Sabarkantha, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231GJ1994PTC023743
-
Company No.
023743
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Dec 1994
-
Date of AGM
31 Jul 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Montage Pharmaceuticals Pvt Ltd offer?
Montage Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pharma Franchise, Veterinary PCD Pharma Franchise.
Who are the key members and board of directors at Montage Pharmaceuticals?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shripal Shah
|
Director | 15-Feb-2000 | Current |
|
Kantilal Shah
|
Director | 15-Feb-2000 | Current |
|
Shrenik Shah
|
Director | 09-Mar-2021 | Current |
|
Suchita Ankolekar
|
Director | 09-Mar-2021 | Current |
|
Vijay Tagwale
|
Director | 09-Mar-2021 | Current |
|
Denis Dsouza
|
Director | 09-Mar-2021 | Current |
Financial Performance of Montage Pharmaceuticals.
Montage Pharmaceuticals Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 38.66% decrease. The company also saw a substantial fall in profitability, with a 18.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 148.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Montage Pharmaceuticals?
In 2020, Montage Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Montage Laboratories Private LimitedShripal Shah, Shrenik Shah and 5 more are mutual person
-
Raptakos Pharma Private LimitedVijay Tagwale is a mutual person
-
Raptakos Solar Private Limited
Vijay Tagwale is a mutual person
-
Raptakos Brett And Company Limited
Vijay Tagwale is a mutual person
-
Briltex Healthcare Private LimitedShripal Shah is a mutual person
-
Raptakos Brett Marketing Private Limited
Suchita Ankolekar is a mutual person
Charges (Loans)
₹0
₹336.00 M
Charges Breakdown by Lending Institutions
- Others : 33.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2017 | Others | ₹33.60 Cr | Satisfied |
How Many Employees Work at Montage Pharmaceuticals?
Unlock and access historical data on people associated with Montage Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Montage Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Montage Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.